Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean M Connors

Showing results (121-130 of 277) with videos related to

Pageof 28
Sort By:
The Journal of Emergency Medicine|October 5, 2015
Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical CenterOmar Al-Majzoub, Eva Rybak, David P Reardon, et al.
The New England Journal of Medicine|November 6, 2009
Clinical problem-solving. A bloody mysteryAdam Cuker, Jean M Connors, Joel T Katz, et al.
Journal of Thrombosis and Thrombolysis|September 21, 2022
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopeniaAsmaa Albuloushi, Megan Rhoten, Julie Kelly, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2025
Low concentrations of recombinant activated factor VII normalize coagulation patterns by reversing the changes in viscoelastic testing parameters induced by abelacimab <i>in vitro</i>Yasser Khder, Serge Côté, Klaus Peter Hoffmann, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2026
Management of anticoagulation in patients with heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass: Guidance from the ISTH SSC on Perioperative and Critical Care Haemostasis and ThrombosisAllyson M Pishko, Corinne Frere, Cheryl L Maier, et al.
Research and Practice in Thrombosis and Haemostasis|June 18, 2020
Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and HaemostasisJerrold H Levy, Jean M Connors, Marie E Steiner, et al.
American Journal of Hematology|March 31, 2022
Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trialJean M Connors, Maria M Brooks, Frank C Sciurba, et al.
Critical Pathways in Cardiology|January 29, 2024
Impact of as Needed Heparin Boluses on Supratherapeutic Activated Partial Thromboplastin Time in Patients Managed With Extracorporeal Membrane OxygenationDelaney M Corcoran, Mary P Kovacevic, Heather Dell'Orfano, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2026
Anaphylaxis and Coagulopathy: From Rare Case Reports to Mechanistic InsightsJerrold H Levy, Cheryl L Maier, Joseph R Shaw, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2025
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH: replyJerrold H Levy, Joseph R Shaw, Jean M Connors, et al.
Pageof 28

Showing results (121-130 of 277) with videos related to

Sort By:
Pageof 28
The Journal of Emergency Medicine|October 5, 2015
Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical CenterOmar Al-Majzoub, Eva Rybak, David P Reardon, et al.
The New England Journal of Medicine|November 6, 2009
Clinical problem-solving. A bloody mysteryAdam Cuker, Jean M Connors, Joel T Katz, et al.
Journal of Thrombosis and Thrombolysis|September 21, 2022
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopeniaAsmaa Albuloushi, Megan Rhoten, Julie Kelly, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2025
Low concentrations of recombinant activated factor VII normalize coagulation patterns by reversing the changes in viscoelastic testing parameters induced by abelacimab <i>in vitro</i>Yasser Khder, Serge Côté, Klaus Peter Hoffmann, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2026
Management of anticoagulation in patients with heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass: Guidance from the ISTH SSC on Perioperative and Critical Care Haemostasis and ThrombosisAllyson M Pishko, Corinne Frere, Cheryl L Maier, et al.
Research and Practice in Thrombosis and Haemostasis|June 18, 2020
Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and HaemostasisJerrold H Levy, Jean M Connors, Marie E Steiner, et al.
American Journal of Hematology|March 31, 2022
Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trialJean M Connors, Maria M Brooks, Frank C Sciurba, et al.
Critical Pathways in Cardiology|January 29, 2024
Impact of as Needed Heparin Boluses on Supratherapeutic Activated Partial Thromboplastin Time in Patients Managed With Extracorporeal Membrane OxygenationDelaney M Corcoran, Mary P Kovacevic, Heather Dell'Orfano, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2026
Anaphylaxis and Coagulopathy: From Rare Case Reports to Mechanistic InsightsJerrold H Levy, Cheryl L Maier, Joseph R Shaw, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2025
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH: replyJerrold H Levy, Joseph R Shaw, Jean M Connors, et al.
Pageof 28